Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01100931 |
|---|---|
| Brief Title: | A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II) |
| First Submitted : | April 8, 2010 |
| First Submitted that Met QC Criteria : | April 8, 2010 |
| First Posted : | April 9, 2010 (Estimate) |
| Results First Submitted : | February 21, 2013 |
| Results First Submitted that Met QC Criteria : | February 21, 2013 |
| Results First Posted : | April 4, 2013 (Estimate) |
| Last Update Submitted that Met QC Criteria : | September 29, 2015 |
| Last Update Posted : | October 19, 2015 (Estimate) |